Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
If RNA editing could be rationally directed to mutated RNA sequences, genetic diseases caused by certain base substitutions could be treated. Here we use a synthetic complementary RNA oligonucleotide to direct the correction of a premature stop codon mutation in dystrophin RNA. The complementary RNA oligonucleotide was hybridized to a premature stop codon and the hybrid was treated with nuclear extracts containing the cellular enzyme double-stranded RNA adenosine deaminase. When the treated RNAs were translated in vitro, a dramatic increase in expression of a downstream luciferase coding region was observed. The cDNA sequence data are consistent with deamination of the adenosine in the UAG stop codon to inosine by double-stranded RNA adenosine deaminase. Injection of oligonucleotide-mRNA hybrids into Xenopus embryos also resulted in an increase in luciferase expression. These experiments demonstrate the principle of therapeutic RNA editing.
Backus,
Only cytidines 5' of the apolipoprotein B mRNA mooring sequence are edited.
1994, Pubmed
Backus,
Only cytidines 5' of the apolipoprotein B mRNA mooring sequence are edited.
1994,
Pubmed Bartel,
Isolation of new ribozymes from a large pool of random sequences [see comment].
1993,
Pubmed Bass,
A developmentally regulated activity that unwinds RNA duplexes.
1987,
Pubmed
,
Xenbase Bass,
An unwinding activity that covalently modifies its double-stranded RNA substrate.
1988,
Pubmed
,
Xenbase Blum,
A model for RNA editing in kinetoplastid mitochondria: "guide" RNA molecules transcribed from maxicircle DNA provide the edited information.
1990,
Pubmed Bulman,
Point mutation in the human dystrophin gene: identification through western blot analysis.
1991,
Pubmed Dai,
Cleavage of an amide bond by a ribozyme.
1995,
Pubmed Dominski,
Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
1993,
Pubmed Higuchi,
RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency.
1993,
Pubmed Lamond,
2'-O-alkyloligoribonucleotides: probes for studying the biochemistry and cell biology of RNA processing.
1993,
Pubmed Maher,
Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system.
1988,
Pubmed Melton,
Injected anti-sense RNAs specifically block messenger RNA translation in vivo.
1985,
Pubmed
,
Xenbase Monia,
Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
1992,
Pubmed Navaratnam,
The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase.
1993,
Pubmed
,
Xenbase Polson,
Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase.
1994,
Pubmed Rebagliati,
Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity.
1987,
Pubmed
,
Xenbase Roberts,
Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations.
1994,
Pubmed Saccomanno,
The cytoplasm of Xenopus oocytes contains a factor that protects double-stranded RNA from adenosine-to-inosine modification.
1994,
Pubmed
,
Xenbase Scaringe,
Chemical synthesis of biologically active oligoribonucleotides using beta-cyanoethyl protected ribonucleoside phosphoramidites.
1990,
Pubmed Simpson,
RNA editing--a novel genetic phenomenon?
1990,
Pubmed Sullenger,
Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing.
1994,
Pubmed Wagner,
A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs.
1989,
Pubmed
,
Xenbase
